PL2328594T3 - Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS - Google Patents
Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRSInfo
- Publication number
- PL2328594T3 PL2328594T3 PL09786159.5T PL09786159T PL2328594T3 PL 2328594 T3 PL2328594 T3 PL 2328594T3 PL 09786159 T PL09786159 T PL 09786159T PL 2328594 T3 PL2328594 T3 PL 2328594T3
- Authority
- PL
- Poland
- Prior art keywords
- stem cells
- adipose tissue
- cells derived
- stromal stem
- derived form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0814249.9A GB0814249D0 (en) | 2008-08-04 | 2008-08-04 | Uses of mesenchymal stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2328594T3 true PL2328594T3 (pl) | 2016-09-30 |
Family
ID=39767494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL09786159.5T PL2328594T3 (pl) | 2008-08-04 | 2009-08-03 | Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS |
Country Status (12)
Country | Link |
---|---|
US (2) | US20120027730A1 (pl) |
EP (2) | EP2328594B1 (pl) |
JP (3) | JP6178970B2 (pl) |
KR (2) | KR101974842B1 (pl) |
AU (1) | AU2009278853B2 (pl) |
CA (2) | CA2732908C (pl) |
DK (1) | DK2328594T3 (pl) |
ES (1) | ES2575165T3 (pl) |
GB (1) | GB0814249D0 (pl) |
HU (1) | HUE029213T2 (pl) |
PL (1) | PL2328594T3 (pl) |
WO (1) | WO2010015929A2 (pl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
ES2313805B1 (es) * | 2004-10-04 | 2009-12-23 | Cellerix, S.L. | Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral. |
GB0814249D0 (en) * | 2008-08-04 | 2008-09-10 | Cellerix Sa | Uses of mesenchymal stem cells |
EP3150703A1 (en) | 2009-07-09 | 2017-04-05 | TiGenix, S.A.U. | Cells for use in a method for treating inflammatory and/or immune disorders |
KR101900664B1 (ko) * | 2011-01-12 | 2018-09-21 | 타이제닉스, 에스.에이.유. | 자가면역 및 염증성 질환에서 림프내 투여를 위한 지방-유래 중간엽 줄기 세포 |
CN103547275B (zh) | 2011-04-06 | 2016-12-28 | 桑比欧公司 | 用于调节外周免疫功能的方法和组合物 |
US20140134140A1 (en) * | 2012-11-09 | 2014-05-15 | Case Western Reserve University | Mesenchymal stem cell compositions for the treatment of microbial infections |
EP3066193B1 (en) * | 2013-11-04 | 2024-07-10 | Isopogen Pty Ltd | Cell culture method |
US20170166869A1 (en) * | 2014-02-04 | 2017-06-15 | Jose Javier Lopez GONZALEZ | Biologically optimized adult mesenchymal stem cells |
JP6628253B2 (ja) * | 2014-02-11 | 2020-01-08 | ブレインストーム セル セラペウティクス リミテッド | 細胞の適性を判定する方法 |
JP6722599B2 (ja) * | 2014-06-30 | 2020-07-15 | ティジェニクス エス.エー.ユー. | 全身性炎症反応症候群の治療のための間葉系間質細胞 |
GB201604304D0 (en) | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
CN106042962A (zh) * | 2016-06-18 | 2016-10-26 | 合肥松雷信息科技有限公司 | 一种充电桩底座 |
US20190255116A1 (en) * | 2016-10-18 | 2019-08-22 | Osaka University | Kit for preparing disease-treating agent, disease-treating agent and method for preparing disease-treating agent |
CN110520138A (zh) | 2017-02-28 | 2019-11-29 | 洛林大学 | 从华顿氏胶获得的用于治疗脓毒症的间充质干细胞 |
US20220010281A1 (en) | 2018-10-29 | 2022-01-13 | Ottawa Hospital Research Institute | Genetically-engineered mesenchymal stem cells overexpressing aoah and uses thereof |
CN112646773B (zh) * | 2021-01-21 | 2021-12-21 | 华夏源(上海)生物科技有限公司 | 一种高效率的人间充质干细胞诱导分化成脂的方法 |
US20240238348A1 (en) | 2021-05-13 | 2024-07-18 | Stemmed Inc. | Composition and use thereof |
JP2024527558A (ja) * | 2021-07-06 | 2024-07-25 | コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション | 間葉系幹細胞、これから分離された細胞外小胞、及びこれらの用途 |
WO2024110591A1 (en) | 2022-11-23 | 2024-05-30 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Biomarkers predictive of immunomodulatory mesenchymal stromal cells |
CN117224577B (zh) * | 2023-09-21 | 2024-02-27 | 浙江大学 | 干细胞凋亡小体在制备治疗复发性流产的药物中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6546105B1 (en) | 1998-10-30 | 2003-04-08 | Matsushita Electric Industrial Co., Ltd. | Sound image localization device and sound image localization method |
CA2784829C (en) * | 2003-04-01 | 2015-10-06 | United States Of America Department Of Veteran's Affairs | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
EP1727892B1 (en) * | 2004-03-22 | 2012-05-02 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
ES2313805B1 (es) * | 2004-10-04 | 2009-12-23 | Cellerix, S.L. | Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral. |
WO2007039150A2 (en) * | 2005-09-23 | 2007-04-12 | Cellerix, S.L. | Cell populations having immunoregulatory activity, method for isolation and uses |
WO2008036374A2 (en) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogeneic stem cell transplants in non-conditioned recipients |
GB0814249D0 (en) * | 2008-08-04 | 2008-09-10 | Cellerix Sa | Uses of mesenchymal stem cells |
-
2008
- 2008-08-04 GB GBGB0814249.9A patent/GB0814249D0/en not_active Ceased
-
2009
- 2009-08-03 KR KR1020177020962A patent/KR101974842B1/ko active IP Right Grant
- 2009-08-03 CA CA2732908A patent/CA2732908C/en active Active
- 2009-08-03 AU AU2009278853A patent/AU2009278853B2/en active Active
- 2009-08-03 KR KR1020117005274A patent/KR101764643B1/ko active IP Right Grant
- 2009-08-03 DK DK09786159.5T patent/DK2328594T3/en active
- 2009-08-03 ES ES09786159.5T patent/ES2575165T3/es active Active
- 2009-08-03 PL PL09786159.5T patent/PL2328594T3/pl unknown
- 2009-08-03 HU HUE09786159A patent/HUE029213T2/en unknown
- 2009-08-03 WO PCT/IB2009/006597 patent/WO2010015929A2/en active Application Filing
- 2009-08-03 US US13/057,467 patent/US20120027730A1/en not_active Abandoned
- 2009-08-03 CA CA3034718A patent/CA3034718A1/en not_active Abandoned
- 2009-08-03 EP EP09786159.5A patent/EP2328594B1/en active Active
- 2009-08-03 JP JP2011521655A patent/JP6178970B2/ja active Active
- 2009-08-03 EP EP16160083.8A patent/EP3095449A1/en not_active Withdrawn
-
2015
- 2015-09-11 JP JP2015179240A patent/JP6285901B2/ja active Active
-
2017
- 2017-12-15 JP JP2017240190A patent/JP6755850B2/ja active Active
-
2021
- 2021-10-08 US US17/497,779 patent/US20220088084A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB0814249D0 (en) | 2008-09-10 |
US20220088084A1 (en) | 2022-03-24 |
KR20110127111A (ko) | 2011-11-24 |
CA2732908A1 (en) | 2010-02-11 |
HUE029213T2 (en) | 2017-02-28 |
AU2009278853B2 (en) | 2015-09-17 |
AU2009278853A1 (en) | 2010-02-11 |
KR101764643B1 (ko) | 2017-09-05 |
JP6285901B2 (ja) | 2018-02-28 |
DK2328594T3 (en) | 2016-04-04 |
KR20170098933A (ko) | 2017-08-30 |
US20120027730A1 (en) | 2012-02-02 |
JP6178970B2 (ja) | 2017-08-16 |
EP2328594A2 (en) | 2011-06-08 |
KR101974842B1 (ko) | 2019-05-03 |
ES2575165T3 (es) | 2016-06-24 |
EP2328594B1 (en) | 2016-03-16 |
CA3034718A1 (en) | 2010-02-11 |
WO2010015929A2 (en) | 2010-02-11 |
CA2732908C (en) | 2019-06-04 |
EP3095449A1 (en) | 2016-11-23 |
JP6755850B2 (ja) | 2020-09-16 |
JP2011529957A (ja) | 2011-12-15 |
WO2010015929A3 (en) | 2010-04-29 |
JP2018080174A (ja) | 2018-05-24 |
JP2016040256A (ja) | 2016-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2328594T3 (pl) | Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS | |
HUS1800039I1 (hu) | Zsírszövet-eredetû stromális õssejtek alkalmazása sipoly kezelésében | |
HK1196034A1 (zh) | 細胞及組織的冷凍保存用組合物 | |
EP2183358A4 (en) | PROCESS FOR THE PREPARATION OF DERMAL PAPER TISSUE EMPLOYING MESENCHYMAL STEM CELLS | |
IL204566A (en) | Adherent cells from fat or placenta tissue for use in healing | |
HK1216883A1 (zh) | 幹細胞培養 | |
EP2315829A4 (en) | INDUCED PLURIPOTENT STEM CELLS | |
EP2326710A4 (en) | THERAPEUTIC METHODS USING SUSPENSIONS OF CELLS FROM ADIPOSE TISSUES COMPRISING ADIPOCYTES | |
EP2294183A4 (en) | MESENCHYMAL STEM CELLS, COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIAC TISSUE LESIONS | |
SG10201802522SA (en) | Treatment of pluripotent cells | |
IL213260A0 (en) | Methods of deriving differentiated cells from stem cells | |
EP2162141A4 (en) | COMPOSITION FOR THE TREATMENT OF ISCHEMIC ILLNESSURE OF EXTREMITIES WITH FAT TISSUE STEM CELLS | |
IL207036A0 (en) | Stem cell aggregates and methods for making and using | |
HK1169993A1 (en) | Hsl inhibitors useful in the treatment of diabetes hsl | |
EP2212418A4 (en) | METHOD FOR THE CO-CULTIVATION OF CELLS FROM CORD BLOOD AND MENSTRUELLEN STEM CELLS | |
EP2294182A4 (en) | CULTS OF MULTIPOTENT STEM CELLS | |
EP2170394A4 (en) | REGULATORY T CELLS IN ADIPOSIVE TISSUE | |
EP2305223A4 (en) | AGENT FOR THE ACTIVATION OF STEM CELLS | |
ZA201206853B (en) | Composition for use in water treatment | |
GB2473504B (en) | Method for determining the suitability of compounds for use in treating bipolar disorder |